| Literature DB >> 30878572 |
David R Strong1, Eric Leas2, Tara Elton-Marshall3, Olivia A Wackowski4, Mark Travers5, Maansi Bansal-Travers5, Andrew Hyland5, Martha White2, Madison Noble2, K Michael Cummings6, Kristie Taylor7, Annette R Kaufman8, Kelvin Choi9, John P Pierce2.
Abstract
In the US, youth attribute higher levels of harm and addictiveness to cigarettes relative to other tobacco products. Monitoring harm perceptions across a range of tobacco products is important when forecasting risk for experimentation. This study examined data from US youth (N = 10,081) ages 12-17 from the Population Assessment of Tobacco and Health (PATH) Study who completed both Wave 1 (2013-2014) and Wave 2 (2014-2015) interviews. Analyses assessed: (1) trends in perceived harm and addictiveness of products over time, (2) whether perceived harm and addictiveness of a product at Wave 1 predicted trying that product for the first time by Wave 2, and (3) whether trying a product between Waves 1 and 2 predicted a decrease in one's perceived harm and addictiveness of that product. Levels of perceived harmfulness and addictiveness significantly increased between Wave 1 and Wave 2 for all products (χ2 (range): 7.8-109.2; p's ≤ 0.02). Compared to those with "high" perceived harmfulness of a tobacco product at Wave 1, those with "low" and "medium" perceived harmfulness had a significantly increased probability of use of that product at Wave 2. For all products, Wave 1 youth never tobacco users who tried a product (vs. did not) at Wave 2 had a significantly higher probability of being in the "low" category of perceived harmfulness at Wave 2. Among US youth, there is a bidirectional relationship between harm perceptions and product use. Understanding how changes in perceptions translate to changes in tobacco use could inform efforts to prevent tobacco initiation in youth.Entities:
Keywords: Tobacco addiction perception; Tobacco harm perceptions; Youth tobacco prevention
Mesh:
Year: 2019 PMID: 30878572 PMCID: PMC7443099 DOI: 10.1016/j.ypmed.2019.03.017
Source DB: PubMed Journal: Prev Med ISSN: 0091-7435 Impact factor: 4.018